Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

CAPS Rating: 3 out of 5

A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions.

Recs

0
Player Avatar kodiakcap (96.61) Submitted: 4/14/2009 3:06:12 PM : Outperform Start Price: $17.95 ALXN Score: +354.79

earnings

Featured Broker Partners


Advertisement